Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEIH.L Regulatory News (EIH)

  • There is currently no data for EIH

Company Update

9 Feb 2012 07:00

RNS Number : 0751X
EIH PLC
09 February 2012
 



 

EIH plc

 

("EIH" or the "Company")

Company Update

On 29 September 2011, the Company announced that 92.15% of Evolvence India Fund's (EIF) committed capital had been drawn down and EIH's outstanding commitment to EIF was US$3.5m.

 

As of today the Company can report that, following a cash call of US$3.2m, 100% of EIF's committed capital has been drawn down and EIH has no outstanding commitment to EIF.

 

Furthermore, the Company's net cash balances currently amount to approximately US$1.3m.

As at today the Company has US$31.8m invested in EIF (capital called of US$45.1m, less refund of capital contributions of US$13.3m), equivalent to 49.3 cents per share. As at today the fair value (unaudited) of the Company's investment in EIF was US$34.3m, equivalent to 53.2 cents per share, representing a 1.08 X multiple over cost. This calculation is based on EIF's 30 September 2011 unaudited financials and includes the US$3.2m draw down referred to above.

Since their appointment on 17 May 2010, the new Board of Directors, has returned US$11.7m in cash to shareholders (18 cents per share), while capital commitments have been reduced from US$12.6m to zero. In addition, operating costs have been substantially reduced.

The Company has today published a fact sheet on its website which contains certain information pertaining EIF's portfolio as at 30 September 2011. 

 

Contacts:

 

EIH plc

 

Rhys Davies / Brett Miller

 

 

+41 (0)796200215 / +44 (0)7770447338

 

 

 

Singer Capital Markets Limited

 

James Maxwell

 

 

+44 (0)20 3205 7500

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUWSNRUVAURAR
Date   Source Headline
7th May 202011:49 amRNSResult of EGM and Notice of Cancellation
7th Apr 20207:00 amRNSProposed AIM Cancellation and Notice of EGM
2nd Apr 20205:38 pmRNSReturn of Capital and COVID-19 Update
6th Dec 20197:00 amRNSReturn of Capital
29th Nov 20197:00 amRNSDelisting Update
21st Nov 20197:00 amRNSMarket Update
30th Sep 20194:30 pmRNSInterim Results
30th Jul 201911:15 amRNSResult of AGM
28th Jun 20197:00 amRNSPosting of 2018 Annual Results and Notice of AGM
24th May 20195:53 pmRNSHolding(s) in Company
1st May 20197:00 amRNSReturn of Capital
4th Apr 20195:00 pmRNSSale of RSB and Return of Capital
25th Jan 20197:00 amRNSHolding(s) in Company
21st Jan 20196:13 pmRNSHolding(s) in Company
18th Jan 201911:37 amRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
26th Jul 201811:05 amRNSResult of AGM
28th Jun 20187:00 amRNSPosting of 2017 Annual Report and Notice of AGM
28th Jun 20187:00 amRNSReturn of Capital
20th Mar 20181:00 pmRNSReplacement: Return of Capital
20th Mar 20187:00 amRNSReturn of Capital
29th Sep 20175:17 pmRNSHalf-year Report
29th Sep 20175:13 pmRNSReturn of capital
24th Jul 201710:54 amRNSResults of Annual General Meeting
26th Jun 20176:01 pmRNSDirectorate Change
26th Jun 20176:00 pmRNSPosting of 2016 Annual Report and Notice of AGM
9th Feb 20178:05 amRNSReturn of Capital
26th Jan 20175:08 pmRNSHolding(s) in Company
25th Jan 20179:30 amRNSHolding(s) in Company
5th Jan 20177:00 amRNSUpdate re EIF
30th Sep 20167:00 amRNSHalf-year Report
25th Jul 20161:24 pmRNSResult of AGM
27th Jun 20165:37 pmRNSPosting of Annual Report & Notice of AGM
27th Jun 20167:00 amRNSReturn of Capital
27th Jun 20167:00 amRNSFinal Results
30th Nov 20155:57 pmRNSHolding(s) in Company
30th Sep 20157:00 amRNSInterim Results
30th Jun 201511:53 amRNSResult of AGM
9th Jun 20154:00 pmRNSNotice of AGM
5th Jun 20154:35 pmRNSFinal Results
30th Sep 20147:00 amRNSHalf Yearly Report
14th Jul 20143:19 pmRNSReturn of Capital
30th Jun 201411:57 amRNSResult of AGM
4th Jun 20147:00 amRNSNotice of AGM
3rd Jun 20147:00 amRNSFinal Results
3rd Dec 201311:16 amRNSHolding(s) in Company
2nd Dec 20134:09 pmRNSHolding(s) in Company
28th Nov 20135:14 pmRNSHolding(s) in Company
27th Nov 20133:14 pmRNSSale of Interest in Gland Pharma Limited
22nd Nov 20139:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.